MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1

J Med Genet. 2023 Jun;60(6):576-577. doi: 10.1136/jmg-2022-109055. Epub 2023 Mar 9.
No abstract available

Keywords: Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Genetic Counselling; Genetic Predisposition to Disease; Genetic Testing; gynaecology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BRCA1 Protein / genetics
  • Breast Neoplasms* / genetics
  • Female
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Humans
  • MutS Homolog 2 Protein / genetics
  • Mutation
  • Ovarian Neoplasms* / genetics

Substances

  • BRCA1 Protein
  • MSH2 protein, human
  • MutS Homolog 2 Protein
  • BRCA1 protein, human